The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pirfenidone APS 534 mg Film-coated tablets



Axunio Pharma GmbHPA23438/002/002

Main Information

Trade NamePirfenidone APS 534 mg Film-coated tablets
Active SubstancesPirfenidone
Dosage FormFilm-coated tablet
Licence HolderAxunio Pharma GmbH
Licence NumberPA23438/002/002

Group Information

ATC CodeL04AX05 pirfenidone

Status

License statusAuthorised
Licence Issued14/04/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0127-174-003
Interchangeable List DocumentPDF of Interchangeable List
« Back